Lobectomy beats stereotactic body radiotherapy survival in early-stage non-small-cell lung cancer

For stage I non-small-cell lung cancer, survival is better with lobectomy than stereotactic body radiotherapy, although there is no difference for sub-lobar resection and stereotactic body radiotherapy, according to a study published online Nov. 29 in the Annals of Thoracic Surgery.
Doctors Lounge